Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Pilot Study on Tailored Eradication Therapy According to Clarithromycin Resistance in Helicobacter Pylori Patients

NCT02648659 is registered in ClinicalTrials.gov with Kyungpook National University Hospital as lead sponsor.

NCT NCT02648659
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02648659 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Pilot Study on Tailored Eradication Therapy According to Clarithromycin Resistance in Helicobacter Pylori Patients
Lead sponsor
Kyungpook National University Hospital
Phase
Phase 4
Overall status
Completed
Start date
March 2, 2016
Completion date
February 14, 2017
Enrollment
50 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

peptic ulcer